Resources

TRO - Celebrating 10 Successful Years

To acknowledge 10 years of operation in 2021, we put together a review of our achievements to celebrate all things TRO - from funding successes, drug discoveries and project progressions from preclinical to clinical, to spin out contributions and the development of long-term industry relationships. 

We also highlight how our vision and values in the areas of Research, Innovation and Education contribute to wider UCL goals and how we will continue to build on an increasingly vibrant translational culture over the next 10 years.  

Galvanising the scientific community towards a common goal during a pandemic

Jane Kinghorn, Director at UCL Translational Research Office and Nick McNally, Managing Director Research UCL/UCLH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic. 

Partnerships are key to biomedical translational success

Jane Kinghorn, UCL TRO Director and Anne Lane, CEO at UCL Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at UCL and their partner hospitals.

Translational education and training for early career researchers

In this interview, Colby Benari, Head of the Academic Careers Office (ACO) at UCL, discusses the role and impact of the UCL ACO and highlights new translational training opportunities for Early Career Researchers. 

Academia: An important player in the drug discovery ecosystem

Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office) at UCL, explain the value of drug discovery in academia in bridging the "Valley of Death".

The innovation game

Professor David Lomas discusses the Therapeutic Innovation Networks (TINs), which are facilitating and accelerating enterprise at University College London (UCL),

UCL: A global partner for health research & innovation

Jane Kinghorn, along with Marta Ribeiro, Felipe Fouto, and Colby Benari from UCL, argue that the ability to listen and learn makes UCL a global partner of choice for health research and innovation. 

Translating novel science to patient benefit

Dr Jane Kinghorn discusses how University College London (UCL)’s Translational Research Office (TRO) is working to encourage, facilitate and contribute to the translation of UCL’s and its partner hospitals’ research.

Cell, Gene and Regenerative Therapies at UCL and NHS Partner Trusts

UCL in partnership with our three NIHR BRCs at University College London Hospital (UCLH), Great Ormond Street Hospital for Children (GOSH) and Moorfields Eye Hospital (MEH) are world leaders in the development and delivery to patients of novel cell, gene and regenerative therapies. 

UCL supporting Healthcare Leadership and Innovation capacity building in Africa

In late 2018, UCL’s Academic Careers Office (ACO) and Translational Research Office (TRO) along with UCL partner the Africa Health Research Institute (AHRI), were successful in applying for a UKRI Global Challenge Research Fund Impact Acceleration Award (GCRF IAA). The ACO and TRO organised two events in South Africa open to participants from across the African continent.